Published
Dr. Leah Croll, a neurology professor at Temple University, breaks down promising findings with the new Alzheimer's drug lecanemab.
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
01:19
‘Remarkable’ drug reduces Alzheimer’s decline, study shows
-
02:22
Data shows drug slowing Alzheimer’s but doubts over effect remain
-
03:53
New drug can slow the development of Alzheimer's
-
08:28
MAGA Sounds Off On Trump's Cognitive Decline
-
01:54
Study shows dramatic decline in effectiveness of all three COVID-19 vaccines over time
-
01:35
US government approves Alzheimer’s drug to slow cognitive decline
-
05:25
The cognitive decline of Biden is palpable: Jason Chaffetz
-
01:47
Eli Lilly study shows Alzheimer's drug slows disease
-
10:18
'Progressive' illness could be behind Biden's cognitive decline: Physician
-
02:26
Drug found to slow Alzheimer’s by up to 60 percent in trial
-
05:50
Piers Morgan: It is clear Biden is in cognitive decline
-
12:34
An Alzheimer’s Drug That Doesn’t Treat Alzheimer’s?
-
07:06
Study shows costly weight loss drug may also cut risks of heart attacks
-
06:12
Hannity: Biden suffers from ‘obvious’ cognitive decline
-
09:50
‘KNOWN FOR MONTHS’: Biden’s cognitive decline apparent after 1st debate
-
10:57
'CAN'T DO THE JOB': Former WH physician warns about Biden's cognitive decline
-
06:50
'He's gone!': Dave Portnoy unleashes on Biden's cognitive decline
-
04:50
FDA approves new drug to slow progression of Alzheimer's
-
08:52
STUDY: Low Wages Linked To Increased Cognitive Decline
-
09:59
Hannity: This is the 'Joe Biden cognitive decline cover-up'
-
03:10
First drug to slow Alzheimer's hailed as momentous - BBC News
-
01:41
Alzheimer's drug slows decline but has side-effects
Loading...